YU45012B - Process for obtaining inhibitor of 5-lipoxygenaze - Google Patents

Process for obtaining inhibitor of 5-lipoxygenaze

Info

Publication number
YU45012B
YU45012B YU608/86A YU60886A YU45012B YU 45012 B YU45012 B YU 45012B YU 608/86 A YU608/86 A YU 608/86A YU 60886 A YU60886 A YU 60886A YU 45012 B YU45012 B YU 45012B
Authority
YU
Yugoslavia
Prior art keywords
substituted
lipoxygenaze
inhibitor
obtaining
tetrazol
Prior art date
Application number
YU608/86A
Other languages
English (en)
Other versions
YU60886A (en
Inventor
I Nagakura
S Nakanishi
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of YU60886A publication Critical patent/YU60886A/xx
Publication of YU45012B publication Critical patent/YU45012B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
YU608/86A 1985-04-16 1986-04-15 Process for obtaining inhibitor of 5-lipoxygenaze YU45012B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60080666A JPS61238785A (ja) 1985-04-16 1985-04-16 １、２―ベンゾチアジン類

Publications (2)

Publication Number Publication Date
YU60886A YU60886A (en) 1988-02-29
YU45012B true YU45012B (en) 1991-06-30

Family

ID=13724685

Family Applications (2)

Application Number Title Priority Date Filing Date
YU608/86A YU45012B (en) 1985-04-16 1986-04-15 Process for obtaining inhibitor of 5-lipoxygenaze
YU1110/87A YU44631B (en) 1985-04-16 1987-06-15 Process for obtaining inhibitors of 5-lipoxigenase

Family Applications After (1)

Application Number Title Priority Date Filing Date
YU1110/87A YU44631B (en) 1985-04-16 1987-06-15 Process for obtaining inhibitors of 5-lipoxigenase

Country Status (21)

Country Link
US (1) US4694080A (de)
EP (1) EP0200408B1 (de)
JP (1) JPS61238785A (de)
AT (1) ATE69446T1 (de)
AU (1) AU562532B2 (de)
CA (1) CA1277318C (de)
DD (4) DD269385A5 (de)
DE (1) DE3682424D1 (de)
DK (1) DK170086A (de)
ES (2) ES8800218A1 (de)
FI (1) FI87353C (de)
GR (1) GR860977B (de)
HU (1) HU207862B (de)
IE (1) IE59041B1 (de)
IL (1) IL78501A (de)
NZ (1) NZ215821A (de)
PH (1) PH22452A (de)
PL (2) PL149169B1 (de)
PT (1) PT82385B (de)
YU (2) YU45012B (de)
ZA (1) ZA862790B (de)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3303189A (en) * 1965-03-11 1967-02-07 Smith Kline French Lab 2, 1-benzothiazine-2, 2-dioxides
US3957772A (en) * 1975-05-21 1976-05-18 Warner-Lambert Company Process for the preparation of 4-hydroxy-3-(5-methyl-3-isoxazolylcarbamoyl)-2-methyl-2h-1,2-benzothiazine 1,1-dioxide
US3987038A (en) * 1975-05-21 1976-10-19 Warner-Lambert Company Process for the preparation of {1-[5-(4-hydroxy-2H-1,2-benzothiazin-3-yl)-1,2,4-oxadiazol-3-yl]methyl}ethanone S,S-dioxide

Also Published As

Publication number Publication date
GR860977B (en) 1986-08-06
IL78501A (en) 1991-03-10
YU60886A (en) 1988-02-29
US4694080A (en) 1987-09-15
IE59041B1 (en) 1993-12-15
ZA862790B (en) 1987-11-25
DD269385A5 (de) 1989-06-28
JPS61238785A (ja) 1986-10-24
ES554005A0 (es) 1987-10-16
PT82385B (pt) 1988-10-14
PL149169B1 (en) 1990-01-31
PL149788B1 (en) 1990-03-31
DD273257A5 (de) 1989-11-08
FI87353C (fi) 1992-12-28
ATE69446T1 (de) 1991-11-15
DK170086D0 (da) 1986-04-15
IL78501A0 (en) 1986-08-31
EP0200408A1 (de) 1986-11-05
PH22452A (en) 1988-09-12
YU44631B (en) 1990-10-31
DD258010A5 (de) 1988-07-06
DD269386A5 (de) 1989-06-28
HU207862B (en) 1993-06-28
DE3682424D1 (de) 1991-12-19
ES557555A0 (es) 1988-07-16
ES8800218A1 (es) 1987-10-16
AU562532B2 (en) 1987-06-11
YU111087A (en) 1988-06-30
CA1277318C (en) 1990-12-04
PT82385A (en) 1986-05-01
IE860979L (en) 1986-10-16
FI861587A0 (fi) 1986-04-15
EP0200408B1 (de) 1991-11-13
JPH058711B2 (de) 1993-02-02
FI87353B (fi) 1992-09-15
ES8802519A1 (es) 1988-07-16
PL268860A1 (en) 1988-07-07
DK170086A (da) 1986-10-17
FI861587A (fi) 1986-10-17
NZ215821A (en) 1988-09-29
AU5610086A (en) 1986-10-23
HUT42086A (en) 1987-06-29

Similar Documents

Publication Publication Date Title
SG119294G (en) 1,2-benzisoxazol-3-yl and 1,2-benzisothiazol-3-yl derivatives
FR2509642B1 (fr) Outil de tournage pour l'usinage des bouts d'arbres, de tourillons, de tubes et analogues
ZA878675B (en) Pharmaceutical compositions containing diltiazem and an enzyme inhibitor
FI941776A0 (fi) Menetelmä 1,2,4-tiadiatsolien valmistamiseksi
AU573754B2 (en) N-substituted nitromethylene tetrahydro thiazoles, thiazines and thiazepines
YU45012B (en) Process for obtaining inhibitor of 5-lipoxygenaze
IE852852L (en) Benzothiazine dioxide salt.
MX9704035A (es) 1,1-dioxidos de 2-(fosfiniloximetil)-1,2,5-tiadiazolidin-3-ona substituidos y composiciones y metodo de uso de los mismos.
MX9704036A (es) 1,1-dioxidos y composiciones de 2-(2,3,5,6-tetrafluoro-4-piridil)-1,2,5-thiadizaolidin-3-ona y metodo de uso.
IL92328A0 (en) Certain substituted 3-azolyl-1,2-benzothiazine 1,1-dioxides and their use for the preparation of certain other such compounds
YU148283A (en) Process for the manufcture of n-(2-pyrridyl)-2-methyl-4-hydroxy-2h-1,2-benzothiazine-3-carboxamide-1,1-dioxide
YU72283A (en) Process for the manufcture of n-(2-pyrridyl)-2-alkyl-4-hydroxy-2h-1,2-benzothiazine-3-carboxamide-1,1-dioxide
IT1140281B (it) Procedimento per la preparazione di 4-idrossi-2-metil-n-(2-piridil)-2h-1,2-benzotiazin-3-carbossamide 1,1-diossido